; and (ii) if the person is injured by the failure to comply described in clause (i). (B) Scope In an action brought under subparagraph (A), if the court finds by a preponderance of the evidence that the application described in that subparagraph failed to comply with the requirement under section 202(c)(6), the court shall cancel as unpatentable any claim of the patent issuing from that application. (2) Inter partes review Section 311 of title 35, United States Code, is amended by striking subsection (b) and inserting the following: (b) Scope A petitioner in an inter partes review may request to cancel as unpatentable 1 or more claims of a patent— (1) (A) on a ground that could be raised under section 102 or 103; and (B) on the basis of prior art consisting of patents or printed publications; or (2) on the ground that the application with respect to the patent was subject to the requirement in section 202(c)(6) and failed to comply with that requirement. . (c) Disclosure of grants Section 111(a)(2) of title 35, United States Code, is amended— (1) in subparagraph (B), by striking and at the end; (2) in subparagraph (C), by striking the period and inserting ; and ; and (3) by adding at the end the following: (D) with respect to a drug (as defined in section 201 of the Federal Food, Drug, and Cosmetic Act) covered by a qualifying patent on the drug, on a method of using such drug, or on a method or machine used to manufacture or administer such drug, a disclosure of any Federal grant received in the 10-year period prior to submitting the application, in which the applicant is listed as the principal investigator or co-investigator with respect to the grant. . (d) GAO report Not later than 5 years after the date of enactment of this Act, and once every 5 years thereafter, the Comptroller General of the United States shall— (1) conduct a study that reviews— (A) the compliance by covered contractors with the requirement under section 202(c)(6)